Shih W - Search Results

1

Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last?

Kim S, Moore DF, Shih W, Lin Y, Li H, Shao YH, Shen S, Lu-Yao GL. Kim S, et al. Among authors: shih w. J Urol. 2013 Jan;189(1):116-21. doi: 10.1016/j.juro.2012.08.091. Epub 2012 Nov 16. J Urol. 2013. PMID: 23164376 Free PMC article.

2

Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.

Yang J, Yang JM, Iannone M, Shih WJ, Lin Y, Hait WN. Yang J, et al. Among authors: shih wj. Cancer Res. 2001 May 15;61(10):4010-6. Cancer Res. 2001. PMID: 11358819

3

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.

DiPaola RS, Chenven ES, Shih WJ, Lin Y, Amenta P, Goodin S, Shumate A, Capanna T, Cardiella M, Cummings KB, Aisner J, Todd MB. DiPaola RS, et al. Among authors: shih wj. Cancer. 2001 Oct 15;92(8):2065-71. doi: 10.1002/1097-0142(20011015)92:8<2065::aid-cncr1546>3.0.co;2-k. Cancer. 2001. PMID: 11596021 Clinical Trial.

4

Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials.

Lin Y, Shih WJ. Lin Y, et al. Among authors: shih wj. Biostatistics. 2001 Jun;2(2):203-15. doi: 10.1093/biostatistics/2.2.203. Biostatistics. 2001. PMID: 12933550

5

A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy.

Toppmeyer DL, Gounder M, Much J, Musanti R, Vyas V, Medina M, Orlando T, Pennick M, Lin Y, Shih W, Goodin S, Rubin E. Toppmeyer DL, et al. Among authors: shih w. Med Sci Monit. 2003 Aug;9(8):PI99-104. Med Sci Monit. 2003. PMID: 12942041 Clinical Trial.

6

Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.

Saraiya B, Gounder M, Dutta J, Saleem A, Collazo C, Zimmerman L, Nazar A, Gharibo M, Schaar D, Lin Y, Shih W, Aisner J, Strair RK, Rubin EH. Saraiya B, et al. Among authors: shih w. Anticancer Drugs. 2008 Apr;19(4):411-20. doi: 10.1097/CAD.0b013e3282f5218b. Anticancer Drugs. 2008. PMID: 18454051 Clinical Trial.

7

Survival following primary androgen deprivation therapy among men with localized prostate cancer.

Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Lu-Yao GL, et al. Among authors: shih w. JAMA. 2008 Jul 9;300(2):173-81. doi: 10.1001/jama.300.2.173. JAMA. 2008. PMID: 18612114 Free PMC article.

8

Failure to report financial disclosure information.

Lu-Yao G, Albertsen P, Shih W, Yao SL. Lu-Yao G, et al. Among authors: shih w. JAMA. 2009 Jan 7;301(1):35-6. doi: 10.1001/jama.2008.905. JAMA. 2009. PMID: 19126808 No abstract available.

9

Contemporary risk profile of prostate cancer in the United States.

Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, Dipaola RS, Lu-Yao GL. Shao YH, et al. Among authors: shih w. J Natl Cancer Inst. 2009 Sep 16;101(18):1280-3. doi: 10.1093/jnci/djp262. Epub 2009 Aug 27. J Natl Cancer Inst. 2009. PMID: 19713548 Free PMC article.

10

Outcomes of localized prostate cancer following conservative management.

Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL. Lu-Yao GL, et al. Among authors: shih w. JAMA. 2009 Sep 16;302(11):1202-9. doi: 10.1001/jama.2009.1348. JAMA. 2009. PMID: 19755699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,091 results

Search Page

Filters